75 related articles for article (PubMed ID: 24380688)
1. Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men.
Nishiyama Y; Otsuka T; Ueda M; Inagaki H; Muraga K; Abe A; Kawada T; Katayama Y
J Neurol Sci; 2014 Mar; 338(1-2):87-91. PubMed ID: 24380688
[TBL] [Abstract][Full Text] [Related]
2. The asymmetric dimethylarginine level is associated with the predicted stroke risk in Japanese women.
Muraga K; Nishiyama Y; Otsuka T; Ueda M; Abe A; Katayama Y
J Atheroscler Thromb; 2014; 21(7):640-7. PubMed ID: 24463840
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Mamatha SN; Nagaraja D; Philip M; Christopher R
Clin Chim Acta; 2011 Jan; 412(1-2):139-42. PubMed ID: 20883678
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Nishiyama Y; Ueda M; Katsura K; Otsuka T; Abe A; Nagayama H; Katayama Y
J Neurol Sci; 2010 Mar; 290(1-2):12-5. PubMed ID: 20060545
[TBL] [Abstract][Full Text] [Related]
5. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
6. Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.
Hov GG; Sagen E; Hatlen G; Bigonah A; Åsberg A; Aasarød K
Clin Biochem; 2011 Jun; 44(8-9):642-6. PubMed ID: 21406191
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study.
Rueda-Clausen CF; Córdoba-Porras A; Bedoya G; Silva FA; Zarruk JG; López-Jaramillo P; Villa LA
Eur J Neurol; 2012 Mar; 19(3):417-25. PubMed ID: 21978129
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Wanby P; Teerlink T; Brudin L; Brattström L; Nilsson I; Palmqvist P; Carlsson M
Atherosclerosis; 2006 Apr; 185(2):271-7. PubMed ID: 16055131
[TBL] [Abstract][Full Text] [Related]
10. Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction.
Ioakeimidis N; Vlachopoulos C; Rokkas K; Aggelis A; Terentes-Printzios D; Samentzas A; Alexopoulos N; Stefanadis C
Eur Urol; 2011 Jun; 59(6):948-55. PubMed ID: 21334135
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J
Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction.
Lehmann HI; Goette A; Martens-Lobenhoffer J; Hammwöhner M; Röhl FW; Bukowska A; Ghanem A; Klein HU; Bode-Böger SM
Europace; 2011 Oct; 13(10):1428-35. PubMed ID: 21752828
[TBL] [Abstract][Full Text] [Related]
13. Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry.
Pecchini P; Malberti F; Mieth M; Quinn R; Tripepi G; Mallamaci F; Maas R; Zoccali C; Ravani P
J Nephrol; 2012; 25(6):1016-22. PubMed ID: 22322824
[TBL] [Abstract][Full Text] [Related]
14. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study.
Iribarren C; Husson G; Sydow K; Wang BY; Sidney S; Cooke JP
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):222-9. PubMed ID: 17446800
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Lu TM; Chung MY; Lin CC; Hsu CP; Lin SJ
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1566-72. PubMed ID: 21642363
[TBL] [Abstract][Full Text] [Related]
18. Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?
Işıklar OO; Barutcuoğlu B; Kabaroğlu C; Mutaf I; Özmen D; Bayındır O; Zoghi M; Uluer H
Clin Biochem; 2012 Nov; 45(16-17):1325-30. PubMed ID: 22750146
[TBL] [Abstract][Full Text] [Related]
19. Renal resistance index in renal allograft recipients: a role for ADMA.
Bergmann IP; Böger RH; Marti E; Frey FJ; Schwedhelm E; Eisenberger U
Am J Kidney Dis; 2009 Aug; 54(2):327-33. PubMed ID: 19560848
[TBL] [Abstract][Full Text] [Related]
20. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
